Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$26.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 7 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 59 business days late.
The 12 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Apr 1 | MGX | Metagenomi Therapeutics,… | AGRANT◆ | 276,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | MGX | Metagenomi Therapeutics,… | AGRANT | 46,000 | — | — | +13.8% | Open the original filing on SEC.gov |
| Mar 5 | MGX | Metagenomi Therapeutics,… | SSELL | 1,607 | $1.60 | $2.6K | -0.5% | Open the original filing on SEC.gov |
| Dec 5, 2025 | MGX | Metagenomi Therapeutics,… | SSELL | 1,602 | $1.77 | $2.8K | -0.3% | Open the original filing on SEC.gov |
| Dec 5, 2025 | MGX | Metagenomi Therapeutics,… | GGIFT | 228,462 | — | — | -40.5% | Open the original filing on SEC.gov |
| Dec 1, 2025 | MGX | Metagenomi Therapeutics,… | AGRANT◆ | 225,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 1, 2025 | MGX | Metagenomi Therapeutics,… | AGRANT | 211,000 | $1.60 | $337.6K | +59.5% | Open the original filing on SEC.gov |
| Dec 1, 2025 | MGX | Metagenomi Therapeutics,… | AGRANT | 37,500 | $1.60 | $60K | +11.8% | Open the original filing on SEC.gov |
| Sep 5, 2025 | MGX | Metagenomi Therapeutics,… | SSELL | 1,602 | $1.81 | $2.9K | -0.5% | Open the original filing on SEC.gov |
| Jun 6, 2025 | MGX | Metagenomi Therapeutics,… | SSELL | 6,390 | $1.75 | $11.2K | -2.0% | Open the original filing on SEC.gov |